HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-parietal cell antibodies and pernicious anemia in patients with type 1 diabetes mellitus and multiethnic background.

Abstract
Anti-parietal cell (APC) antibodies and pernicious anemia (PA) were evaluated in patients with type 1 diabetes (n=75) and in controls. A higher frequency of APC (13.3%) and PA (4%) was found in cases than in controls (p=0.003), associated with other autoimmune diseases (p=0.003), but not with insulin or PTPN22 polymorphisms.
AuthorsAlinna Lage Ferraz Pinto, Joana Rodrigues Dantas, Debora Araujo, Bianca Barone, José Ângelo de Souza Papi, José Egídio Paulo de Oliveira, Lenita Zajdenverg, Melanie Rodacki
JournalDiabetes research and clinical practice (Diabetes Res Clin Pract) Vol. 102 Issue 2 Pg. e41-3 (Nov 2013) ISSN: 1872-8227 [Electronic] Ireland
PMID24083984 (Publication Type: Journal Article)
CopyrightCopyright © 2013. Published by Elsevier Ireland Ltd.
Chemical References
  • Autoantibodies
  • Insulin
  • PTPN22 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 22
Topics
  • Adolescent
  • Adult
  • Anemia, Pernicious (blood, complications)
  • Autoantibodies (blood)
  • Case-Control Studies
  • Diabetes Mellitus, Type 1 (blood, complications)
  • Ethnicity
  • Female
  • Humans
  • Insulin (genetics)
  • Male
  • Parietal Cells, Gastric (immunology)
  • Protein Tyrosine Phosphatase, Non-Receptor Type 22 (genetics)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: